5-Hydroxymethyltubercidin. Synthesis, biological activity, and role in pyrrolopyrimidine biosynthesis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000494:pharmacology; D000903:Antibiotics, Antineoplastic / Q000138:chemical synthesis* / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects; D007939:Leukemia L1210 / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D009161:Mycobacterium / Q000187:drug effects; D011743:Pyrimidines / Q000096:biosynthesis / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D011758:Pyrroles / Q000096:biosynthesis / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D012263:Ribonucleosides / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D013056:Spectrophotometry, Ultraviolet; D014372:Tubercidin / Q000031:analogs & derivatives
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D011743:Pyrimidines; D011758:Pyrroles; D012263:Ribonucleosides; C008053:5-hydroxymethyltubercidin; D014372:Tubercidin